Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

AKYA Akoya BioSciences Inc

2,12

-0,04 (-1,85%)

Nach Börsenschluss

Zuletzt aktualisiert: 22:41:01

Verzögert um 15 Minuten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Akoya BioSciences (NASDAQ:AKYA)
Historical Stock Chart
Von Okt 2024 bis Nov 2024

Click Here for more Akoya BioSciences Charts.

Akoya BioSciences (NASDAQ:AKYA)
Historical Stock Chart
Von Nov 2023 bis Nov 2024

Click Here for more Akoya BioSciences Charts.

News Akoya BioSciences Inc

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 14 November 2024 (7 Tage vor) • Edgar (US Regulatory)

Akoya Biosciences Reports Third Quarter 2024 Financial Results
Donnerstag 14 November 2024 (1 Woche vor) • GlobeNewswire Inc.

Akoya Biosciences Unveils a New Era in Spatial Content Innovation with the PhenoCode™ Discovery IO60 and Mouse FFPE IO Panel
Dienstag 5 November 2024 (2 Wochen vor) • GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Montag 4 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

Akoya Bioscience to Report Third Quarter 2024 Financial Results on November 14, 2024
Montag 28 Oktober 2024 (3 Wochen vor) • GlobeNewswire Inc.

Akoya’s Leading Spatial Proteomics Platforms Selected for Use by Ground-Breaking UK-Based MANIFEST Consortium to Revolutionize Cancer Immunotherapy
Montag 7 Oktober 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 8-K - Current report
Donnerstag 3 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Akoya Biosciences Announces Scott Mendel as Chairman of the Board of Directors
Donnerstag 3 Oktober 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 4 September 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Mittwoch 4 September 2024 (3 Monate vor) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Mittwoch 28 August 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 5 August 2024 (4 Monate vor) • Edgar (US Regulatory)

Weitere Akoya BioSciences Inc News-Artikel

Gold vs US Dollar

BNP Paribas (QX)

Health Care Select Sector

Euro vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen